"This center brings highly specialized care and expertise from a leading cancer program and nationally recognized medical oncologists."

During the past decade, Loyola Center for Cancer Care and Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loyola Center for Cancer Care and Research" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Loyola Center for Cancer Care and Research" are "Recurrent Lung Non-Small Cell Carcinoma" (2 trials), "Stage IV Lung Cancer AJCC v8" (2 trials), "Stage IVA Lung Cancer AJCC v8" (2 trials), "Stage IVB Lung Cancer AJCC v8" (2 trials) and "CD20 Positive" (1 trials). Many other conditions were trialed in "Loyola Center for Cancer Care and Research" in a lesser frequency.

Most popular intervention types in "Loyola Center for Cancer Care and Research" are "Biological" (2 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Autologous Hematopoietic Stem Cell Transplantation" (1 trials), "Docetaxel" (1 trials), "Gemcitabine" (1 trials), "Gemcitabine Hydrochloride" (1 trials) and "Laboratory Biomarker Analysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Loyola Center for Cancer Care and Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Loyola Center for Cancer Care and Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Loyola Center for Cancer Care and Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Loyola Center for Cancer Care and Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".